Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

<< Previous

Bullboard Posts

Next >>

Post by MrMugsyon Jun 20, 2022 5:06pm

267 Views

Post# 34769760

Go Samira - more aggressive than she's ever been !!!

Filed 2022-06-20 14:22 Tx date 2022-06-20	$GUD Knight Therapeutics Inc.	Sakhia, Samira 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$99,998 +19,455 vol $5.14 each	158,954